Viral hepatitis is a disease of antiquity, but evidence for more than one etiologic agent has been recognized only since the 1940s, when two viruses (hepatitis A virus and hepatitis B virus) were thought to account for all disease. In the past 20 years, three additional hepatitis agents (hepatitis C virus, hepatitis D virus, and hepatitis E virus) have been discovered, and there is evidence for at least one additional virus. Each of the five recognized hepatitis viruses belongs to a different virus family, and each has a unique epidemiology.
a different virus family, and each has a unique epidemiology. The medical impact ofthese viruses on society has been strongly influenced by changes in human ecology. This has resulted in some cases in diminished disease and in others in increases in the incidence of disease. Viral hepatitis is caused by at least five distinct viruses. Each belongs to an entirely different family of viruses, and they have very little in common except the target organ they affect, the liver, and a certain degree of shared epidemiology. Each of the five viruses has a world-wide distribution. In general, the regional incidence rates for each virus are lowest in the Western Hemisphere and northern regions and highest in the Eastern Hemisphere and tropical regions. Thus, the incidence of infection with these five viruses is generally lowest in industrialized and developed countries and highest in less-developed regions. Two of the viruses [hepatitis A virus (HAV) and hepatitis E virus (HEV)] are spread principally by fecal-oral means and three [hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis D virus (HDV)] are spread principally by exposure to blood, although HBV is frequently spread by unprotected sex. Although it has been sought, arthropod-borne or other vector-mediated transmission of the blood-borne hepatitis viruses has not been found. Other viruses, principally from the families Arenaviridae, Bunyaviridae, Flaviviridae, Filoviridae, and Herpesviridae, also cause hepatitis as part of systemic diseases, but these are generally not grouped with the hepatitis viruses.
Changes in human ecology and behavior have had discernable effects on the epidemiology of the hepatitis viruses in different ways and to different degrees. Following is a brief summary ofeach virus and how it has interacted with its host. In some cases the view is but a glimpse because the existence of three of the five viruses has been recognized for less than 20 years.
Hepatitis A Virus
History. HAV may be traced back to epidemics of "campaign jaundice" that afflicted the armies of the Middle Ages and that has continued to be a serious problem up to and including the Korean and Vietnamese conflicts (see ref. 1) . The first civilian epidemics of hepatitis were recorded in Europe in the 17th and 18th centuries. The differentiation of hepatitis A, then called infectious hepatitis, from hepatitis B, then called serum hepatitis, came principally from studies in volunteers in Europe and the United States from the 1940s through the 1960s. It was not until the 1970s that HAV was transmitted to laboratory animals (marmoset monkeys and chimpanzees), and the virus was isolated in cell culture in 1979 (2) . It remains the only one of the five hepatitis viruses that has been unequivocally isolated and serially propagated in cell culture. Effective inactivated whole virus vaccines have been developed. The first was licensed in Europe in 1991 and two inactivated hepatitis A vaccines should be licensed in the United States within the next 1 or 2 years.
Epidemiology. HAV is commonly transmitted by the fecaloral route, either by person-to-person spread (the most common) or in common-source epidemics caused by contamination of food or water. Viremia occurs during the incubation period and the early acute phase of hepatitis A, and transmission by transfusion or recently by contaminated commercial factor VIII (3) has been reported, but such blood-borne transmissions are rare.
Virology. HAV is classified in the family Picornaviridae, genus Hepatovirus. Based on genomic sequence heterogeneity, seven genotypes of HAV have been identified, but one serotype comprises all of these (4) . The infectivity titer of HAV in the feces may be as high as 109 infectious doses per gram (5) . Viremias lasting as long as several weeks and with titers as high as 105 infectious doses per ml ofblood have been recorded (3, 5) .
Clinical Characteristics. The incubation period of hepatitis A averages 25 days. Hepatitis A is generally mild to moderate in severity, with a mortality rate of 0.2% or less, and never becomes chronic. However, inapparent infection with shedding of virus may persist for up to 6 months in neonates.
Changing Patterns. The epidemiology of HAV is highly influenced by personal and public hygiene. Hepatitis A has diminished in importance over the past several decades in developed and industrialized countries of northern and western Europe and North America (6) . A gradient from northern to southern Europe exists, in which hepatitis A is almost nonexistent in Scandinavian countries but is still present, albeit with diminishing importance, in the Mediterranean countries of Europe. A similar pattern of diminishing incidence of hepatitis A has been seen in other developed and transitional regions, including Australia, China, Japan, and Hong Kong, but HAV infection remains highly endemic in many other regions of Central and Southeast Asia, Africa, Proc. Nadl. Acad. Sci. USA 91 (1994) and Central and South America. As with other picornaviruses such as poliovirus, infection of the very young is usually inapparent, and disease becomes progressively more severe with increasing age. Thus, as the mean age of infection increases with improved sanitation, clinical hepatitis paradoxically becomes more apparent rather than less apparent.
In the United States, hepatitis occurred as recurring epidemics through the 1970s, with 7-to 10-year periodicity (7 Epidemioogy. Transmission of HBV is principally by exposure to blood or blood products, but transmission by unprotected sex (both homosexual and heterosexual) is also common. In Asia, perinatal transmission from the infected mother to her offspring is an important mode of spread, whereas horizontal transmission among very young children is more important in Africa.
Vioo. HBV is classified in the family Hepadnaviridae, genus Orthohepadnavirus. Based upon genomic heterogeneity, five genotypes of HBV have been identified, but one serotype comprises all of these (10) . The infectivity titer of HBV in blood may be 108 or more infectious doses per ml (11) . The virus has been found in saliva and serum and this may contribute to its sexual transmission.
Clinkal. The incubation period of hepatitis B averages 75 days. The disease is usually moderate but may be severe, with a mortality rate of 0.2% to 2%. Disease is less likely to be clinically severe but more likely to become chronic in the very young: >90%6 of infected newborns develop chronic infection, and this progressively diminishes to 6 years of age, when the adult chronicity rate of 2-7% is reached (12) .
Changing Patterns. Since serologic tests for the detection of HBV infection were first applied in the mid-1960s the incidence of hepatitis B progressively increased until the mid-1980s, when it reached a plateau and began to decrease slightly, probably as a result ofintensive efforts to control the spread of human immunodeficiency virus (HIV) in the same high-risk populations. Hepatitis B vaccin appears to have had little impact on the incidence of hepatitis B (13 Cofloquium Paper: PurceU developed diagnostic tests for hepatitis A and hepatitis B to stored samples of prospectively studied cases of transfusionassociated hepatitis revealed that most of the cases were neither hepatitis A nor hepatitis B (15) . The proportion of such "non-A, non-B" (NANB) cases increased from --65% before screening for HBV markers was instituted to >90%o as HBV carriers were excluded from the blood donor population (16) . The "new" hepatitis had an average incubation period of -7-10 weeks, which is intermediate between those of hepatitis A and hepatitis B and similar to the mean incubation period of all cases of transfusion-associated hepatitis in the 1950s and 1960s, suggesting that NANB hepatitis had also been the principal cause of transfusion-associated hepatitis in the past (17) . Although NANB hepatitis was transmitted to chimpanzees in 1978, thus establishing its infectious nature, it was not until 1989 that the virus itself was identified. Indirect evidence of the nature of the virus had been obtained by experiments in chimpanzees: it had been shown to be inactivated by lipid solvents and therefore was probably an enveloped virus, and its size had been estimated at between 30 and 60 nm in diameter. However, in 1989 a small piece of the viral RNA was reverse-transcribed, cloned, and sequenced, and this resulted in the subsequent cloning and sequencing of the entire genome (18) . The virion was only recently tentatively visualized by electron microscopy (19) . Nevertheless, all of the viral proteins encoded by the HCV genome have been expressed, and some of these serve as the basis for currently licensed serologic tests for antibody to HCV.
Epidemiology. HCV is commonly transmitted via blood and blood products. Its transmission by other routes, such as unprotected sex, perinatal transmission from infected mother to offspring, etc., have been proposed but remain controversial and probably of minor importance. However, >40%6 of cases of hepatitis C in the United States have no recognizable risk factor (20) .
Virology. HCV is classified in the family Flaviviridae, in a separate as-yet-unnamed genus. Based on genomic sequence heterogeneity, 6 major and >12 minor genotypes of HCV have been identified (21) . The major genotypes differ from one another to the same degree that other RNA viruses belonging to separate subgenera differ; minor genotypes differ to about the degree that different serotypes of other RNA viruses differ from one another. This suggests that multiple serotypes of HCV exist, but the lack of a convenient in vitro assay system and the failure to demonstrate lasting immunity following infection of chimpanzees, even when the virus used for rechallenge is the same as the original inoculum, suggest that serotypic variation is a prominent feature of HCV. The infectivity titer ofHCV in the blood may be as high as 106 infectious doses per ml but is usually much lower, especially in cases ofchronic infection, apparently because of complexing of virus to antibody (22, 23) . Detection by polymerase chain reaction of HCV genomic RNA in other body fluids has been reported, but it is unclear whether this represents infectious virus.
Clinical Characteristics. The incubation period of hepatitis C averages 50 days. Acute hepatitis A is generally a mild disease with a mortality rate of <1%. However, >50%o of acute cases progress to chronicity, and some of these will eventually progress to cirrhosis or hepatocellular carcinoma or both.
Changing Patterns. Insufficient time has passed since its discovery for us to have a clear picture of the ecology of HCV. Only -0.3% of the normal blood donor population of the United States has antibody to HCV, but the prevalence of anti-HCV in inner city populations may be >50-fold higher (24) . The same inner city populations have very high prevalences of antibody to HBV and HIV, undoubtedly reflecting the high-risk lifestyles of these groups. However, since NANB hepatitis has been reported as a separate entity beginning in the early 1980s, some trends in relative importance of risk factors have emerged (25) . Transfusionassociated NANB hepatitis is virtually disappearing as a result of the current comprehensive screening program that tests specifically for infections with HBV, HCV, and HIV and excludes all who identify themselves as members of high-risk populations. Intravenous drug use as a risk factor has also diminished in relative importance, probably because of efforts to control AIDS in such populations. However, control of NANB hepatitis (principally hepatitis C) in the general population will probably require the development of effective hepatitis C vaccines and their appropriate use.
The impact of hepatitis C in other countries is still being sorted out. Hepatitis C virus has a world-wide distribution, but, surprisingly, the prevalence of anti-HCV is on the order of 1% in most developed countries and <10% in most developing countries surveyed to date. An exception is Egypt, where the prevalence of anti-HCV is 410-20% (26).
Much is yet to be learned about the ecology of HCV. For instance, several of the genotypes of HCV have world-wide distributions but others appear to be limited to certain regions or even countries (21) . A possible connection between certain genotypes of HCV and the clinical course of infection has been reported but not confirmed. Similarly, certain genotypes of HCV appear to be more susceptible to therapy with interferon than others (27) . Finally, coinfection, superinfection, and reinfection with different strains of HCV probably occur as well as the emergence of genetic variants (thought to be neutralization-escape mutants of the virus) over time in chronically infected individuals (28) (29) (30) (31) (32) . Thus, many of the same phenomena observed in infections with HIV, another highly heterogeneous and mutable virus, have been observed in HCV infections. This bodes ill for the rapid development of an effective hepatitis C vaccine, although the first successful steps toward vaccine development have been taken (33) .
Hepatitis D Virus
History. The first evidence for the existence of HDV came in 1978 when a previously unrecognized intranuclear antigen was detected by immunofluorescence in liver biopsies from Italian patients with chronic HBV infection. First thought to be another antigenic specificity of HBV, the antigen was eventually shown to be associated with the capsid protein of a previously unrecognized virus, subsequently called "hepatitis delta virus" (HDV) (34) . The virus was shown to be defective, requiring a helper function from HBV, probably because HDV is enveloped with the envelope of HBV. The transmissible nature of HDV was established in 1980 by transmission of the virus to HBV-infected chimpanzees.
Epidemiology. HDV is commonly transmitted by blood and blood products. Perinatal transmission has been reported but is rare, probably because the perinatal transmission of HBV is uncommon in regions where HDV is prevalent. HDV has been found in indigenous populations of South America, Africa, and certain parts of Central and Southeast Asia, where it has caused outbreaks of severe and often fatal hepatitis. Its modes of spread in such indigenous populations are poorly understood but may include inapparent exposure to blood and, in some cases, sexual transmission. In developed countries, hepatitis D is largely restricted to certain high-risk populations, principally users of illicit parenteral drugs.
Virology. HDV is the most unusual of the hepatitis viruses. It does not resemble any other known animal virus and has been classified with the plant virus satellites, agents that are also related to viroids of plants. Based upon the genetic heterogeneity of the agent's single-stranded circular RNA Cofloquium Paper: Purcefl Proc. Natl. Acad. Sci. USA 91 (1994) genome, three genotypes have been described (35) . It is not clear how many serotypes exist, since the virus is enveloped with the envelope of HBV (HBsAg), from which it probably takes its serologic specificity. HDV achieves extraordinarily high titers (1011 infectious doses per ml) in the blood of infected individuals (36 (43, 44) . Among these was the massive epidemic of hepatitis that occurred in Delhi, India, in 1955-1956 following contamination of a major water treatment plant with raw sewage. The epidemic had been cited previously as a classical example of water-borne hepatitis A, but the subsequent discovery that hepatitis A was highly endemic in Indian populations, with HAV infecting almost 100%6 ofthe population by the age of5-10 years, made it difficult to accept that the Delhi epidemic and other water-borne epidemics that occurred principally in young adults were caused by HAV. Indeed, virtually 1001% of stored serum samples from such epidemics were found to contain IgG anti-HAV but not IgM anti-HAV-strong evidence for past HAV infection with resultant immunity and therefore evidence for the existence of a previously unrecognized hepatitis agent as the cause of the epidemics. HEV was first visualized in 1983 and transmitted to a human volunteer and cynomolgus monkeys, thus establishing its etiologic role in enterically transmitted NANB (ET-NANB) hepatitis (45 More recent interactions between changing human culture and HEV were seen in epidemics of hepatitis E that occurred among refugees living under substandard conditions in Ethiopia and Somalia in the 1980s (50) . Those epidemics could be traced directly to overcrowding, substandard living conditions, and nonexistent sanitation. Such epidemics are likely to occur in the future if HEV is introduced into similar environments that are conducive to explosive spread of fecal-orally transmitted viruses. It was surprising, for example, that hepatitis E epidemics did not occur during the recent Gulf war, since the Norwalk agent, a fecal-orally transmitted calicivirus, did cause significant disease. Perhaps only the absence of HEV from the war zone prevented an epidemic.
Interactions of the Hepatitis Viruses
Not only do changes in the culture of populations alter the epidemiology of the hepatitis viruses, but interactions among the viruses and their hosts further modify the ecology of viral hepatitis. The obligatory interaction between HDV and HBV, leading to much more severe disease, also results in suppression of replication of HBV by mechanisms that are not completely understood but may be related to the expression or action of interferon (51) . Similar suppression of replication of HBV by HAV and HCV has been reported and dual infections of hepatitis viruses are thought usually to result in more severe disease than single infections. One example of this is an epidemic of severe, in some cases fatal, hepatitis B that occurred in Edinburgh, Scotland, in 1969-1970 (52) . Long an enigma because other similar blood-borne epidemics of hepatitis B had not resulted in such catastrophic outcomes, the reason for the severity ofthis outbreak has been doggedly pursued by one of the original investigators, B. Marmion. Over the years, a variety of possible explanations, including coinfection with HDV, were ruled out. Recently, Marmion and his colleagues have provided convincing evidence that the severe hepatitis B in Edinburgh was associated with dual infection with HCV (B. Marmion, personal communication).
Other Hepatitis Viruses
Approximately 10% of transfusion-associated hepatitis and -4% of community-acquired hepatitis in the United States cannot be ascribed to any of the five recognized hepatitis viruses. It has been proposed that these cases may be caused by a previously unrecognized hepatitis virus, but attempts to transmit an agent from such patients to primates have yielded equivocal or negative results. Additional studies must be carried out to determine whether these cases are indeed caused by a new agent or whether their etiology may be noninfectious.
More convincing evidence for an additional, water-borne hepatitis agent has come from recent studies in Asia, where at least two water-borne epidemics of hepatitis appear not to have been caused by any of the recognized hepatitis viruses (53, 54) . Thus, the epidemiology of viral hepatitis continues to evolve.
Conclusions
In summary, changes in human culture have had profound effects on the epidemiology and public health impact of the hepatitis viruses. In some cases, this has been a positive influence; in others it has been negative. For example, progressive improvement in public and personal hygiene over the last century has diminished the medical importance of hepatitis A and, possibly, at an earlier time, hepatitis E. Lapses in sanitation, through war, such as happened in Somalia, or through changing social mores, as has happened among certain groups in the United States, has resulted in increased disease caused by the fecal-orally transmitted hepatitis viruses, confirming the need for constant vigilance.
Similarly, increased sexual promiscuity, whether homosexual or heterosexual, and increasing use ofillicit parenteral drugs has resulted in infection with the blood-borne hepatitis viruses in epidemic proportions. These epidemics were the forerunners of the current HIV epidemic. In most cases, these changes could have been predicted by simple epidemiology, had we the knowledge about the viruses that we now possess. However, preventing outbreaks of disease that are caused by changes in behavior patterns has never been simple or effective, and making an impact on ongoing disease by methods that rely upon changing the behavior of at-risk populations is a difficult and frustrating chore. It is one of the reasons why vaccines, although initially expensive, prove in the long run to be among the most cost-effective ofall medical interventions.
